![Foto de Paula](/img/nophoto.png)
Paula
Aldaz Donamaria
Paula Aldaz Donamaria-rekin lankidetzan egindako argitalpenak (18)
2023
-
Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapy
Nature Metabolism, Vol. 5, Núm. 9, pp. 1544-1562
2022
-
Author Correction: PR-LncRNA signature regulates glioma cell activity through expression of SOX factors (Scientific Reports, (2018), 8, 1, (12746), 10.1038/s41598-018-30836-5)
Scientific Reports
-
High SOX9 Maintains Glioma Stem Cell Activity through a Regulatory Loop Involving STAT3 and PML
International Journal of Molecular Sciences, Vol. 23, Núm. 9
-
SOX9 Triggers Different Epithelial to Mesenchymal Transition States to Promote Pancreatic Cancer Progression
Cancers, Vol. 14, Núm. 4
2021
-
Identification of a dexamethasone mediated radioprotection mechanism reveals new therapeutic vulnerabilities in glioblastoma
Cancers, Vol. 13, Núm. 2, pp. 1-23
2020
-
Methylation of MGMT promoter does not predict response to temozolomide in patients with glioblastoma in Donostia Hospital
Scientific Reports, Vol. 10, Núm. 1
-
SOX9 promotes tumor progression through the axis BMI1-p21CIP
Scientific Reports, Vol. 10, Núm. 1
2019
-
SOX3 can promote the malignant behavior of glioblastoma cells
Cellular Oncology, Vol. 42, Núm. 1, pp. 41-54
2018
-
Indirect costs associated with glioblastoma: Experience at one hospital
Neurologia, Vol. 33, Núm. 2, pp. 121-128
-
PR-LncRNA signature regulates glioma cell activity through expression of SOX factors
Scientific Reports, Vol. 8, Núm. 1
2017
-
High expression of MKP1/DUSP1 counteracts glioma stem cell activity and mediates HDAC inhibitor response
Oncogenesis, Vol. 6, Núm. 12
-
Oncogenic activity of SOX1 in glioblastoma
Scientific Reports, Vol. 7
2016
-
MTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance
Expert Opinion on Therapeutic Targets, Vol. 20, Núm. 4, pp. 393-405
-
SOX9 elevation acts with canonical WNT signaling to drive gastric cancer progression
Cancer Research, Vol. 76, Núm. 22, pp. 6735-6746
-
SOX9-regulated cell plasticity in colorectal metastasis is attenuated by rapamycin
Scientific Reports, Vol. 6
-
Stratification and therapeutic potential of PML in metastatic breast cancer
Nature Communications, Vol. 7
-
Targeting SOX2 as a therapeutic strategy in glioblastoma
Frontiers in Oncology
2013
-
Therapeutic strategies targeting Glioblastoma stem cells
Recent Patents on Anti-Cancer Drug Discovery, Vol. 8, Núm. 3, pp. 216-227